M. Humbert (Clamart, France)
Chair's welcome
M. Humbert (Clamart, France)
| ![]()  ![]() |
Managing severe asthma: do we need to do more?
T. Sandstrom (Umea, Sweden)
| ![]() ![]() |
Anti-IgE therapy: rationale and clinical evidence
R. Niven (Manchester, United Kingdom)
| ![]() ![]() |
Omalizumab in practice: learning from experience
J. Karpel (Great Neck, United States of America), S. Carey (Woking, Surrey, United Kingdom), M. Humbert (Clamart, France)
| ![]() ![]() |
Valuing the real world benefits of omalizumab
S. Sullivan (Seattle, United States of America)
| ![]() ![]() |
Evidence into practice: moving forward with anti-IgE
M. Humbert (Clamart, France)
| ![]() ![]() |